CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 60 enrolled
Drug / intervention
Lidocaine 2% Geldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02268968
NCT02268968Phase 1Completed
CompareCT.gov

Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal Contiuous Positive Airway Pressure

Mansoura University Children Hospital·interventional·Posted Oct 20, 2014·Updated Apr 14, 2015

In Brief

A Phase 1 clinical trial evaluating Lidocaine 2% Gel for Other Preterm Infants. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The main purpose of this study is to evaluate the relative efficacy of topical lidocaine on reducing pain associated with the application of nasal CPAP in preterm infants

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOther Preterm Infants
CountriesEgypt
Collaborators--

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 20, 2014
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.7 years ago

Interventions

Lidocaine 2% Geldrug

Lidocaine 2% gel will be applied to nostrils and nasal CPAP prong 5 minutes prior to application of nasal CPAP